Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIAGNODE-2: Diamyd + Vitamin D in Type 1 Diabetes
NCT03345004Phase 2Completed
- Sponsor
- Diamyd Medical
- Start
- Dec 2017
- Primary completion
- Jul 2020
- Modality
- Recombinant Proteins and Enzymes, Subcutaneous Immunotherapy, Sublingual Immunotherapy
- Countries
- 4
01
Overview
A Phase 2 trial of Diamyd in type 1 diabetes mellitus (T1D), sponsored by Diamyd Medical. Started Dec 2017; status: completed.
02
Drugs
Diamyd
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03345004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03345004.